T0	KEYPHRASE-NOTYPES 0 17	Efficacy analyses
T1	KEYPHRASE-NOTYPES 54 66	participants
T2	KEYPHRASE-NOTYPES 72 87	intent-to-treat
T3	KEYPHRASE-NOTYPES 89 92	ITT
T4	KEYPHRASE-NOTYPES 94 100	sample
T5	KEYPHRASE-NOTYPES 102 114	Lyme patient
T6	KEYPHRASE-NOTYPES 119 135	healthy controls
T7	KEYPHRASE-NOTYPES 155 162	respect
T8	KEYPHRASE-NOTYPES 182 215	baseline clinical characteristics
T9	KEYPHRASE-NOTYPES 223 230	tests
T10	KEYPHRASE-NOTYPES 235 254	continuous measures
T11	KEYPHRASE-NOTYPES 259 261	χ ^
T12	KEYPHRASE-NOTYPES 263 268	tests
T13	KEYPHRASE-NOTYPES 273 293	categorical measures
T14	KEYPHRASE-NOTYPES 295 301	nTests
T15	KEYPHRASE-NOTYPES 306 315	estimates
T16	KEYPHRASE-NOTYPES 319 330	differences
T17	KEYPHRASE-NOTYPES 339 345	groups
T18	KEYPHRASE-NOTYPES 365 372	placebo
T19	KEYPHRASE-NOTYPES 378 394	healthy controls
T20	KEYPHRASE-NOTYPES 401 408	respect
T21	KEYPHRASE-NOTYPES 416 436	multivariate measure
T22	KEYPHRASE-NOTYPES 440 449	cognition
T23	KEYPHRASE-NOTYPES 455 462	domains
T24	KEYPHRASE-NOTYPES 464 469	motor
T25	KEYPHRASE-NOTYPES 471 482	psychomotor
T26	KEYPHRASE-NOTYPES 492 498	memory
T27	KEYPHRASE-NOTYPES 500 509	attention
T28	KEYPHRASE-NOTYPES 511 525	verbal fluency
T29	KEYPHRASE-NOTYPES 532 538	memory
T30	KEYPHRASE-NOTYPES 545 549	time
T31	KEYPHRASE-NOTYPES 551 559	baseline
T32	KEYPHRASE-NOTYPES 561 565	week
T33	KEYPHRASE-NOTYPES 574 578	week
T34	KEYPHRASE-NOTYPES 597 630	longitudinal mixed-effects models
T35	KEYPHRASE-NOTYPES 632 635	LMM
T36	KEYPHRASE-NOTYPES 665 676	correlation
T37	KEYPHRASE-NOTYPES 689 696	domains
T38	KEYPHRASE-NOTYPES 713 736	peated observations
T39	KEYPHRASE-NOTYPES 742 746	time
T40	KEYPHRASE-NOTYPES 757 760	LMM
T41	KEYPHRASE-NOTYPES 770 782	main effects
T42	KEYPHRASE-NOTYPES 791 808	interaction terms
T43	KEYPHRASE-NOTYPES 810 814	Time
T44	KEYPHRASE-NOTYPES 832 846	nominal factor
T45	KEYPHRASE-NOTYPES 861 880	continuous variable
T46	KEYPHRASE-NOTYPES 906 928	three-way interactions
T47	KEYPHRASE-NOTYPES 934 939	model
T48	KEYPHRASE-NOTYPES 948 968	covariance structure
T49	KEYPHRASE-NOTYPES 1002 1031	Bayesian information criteria
T50	KEYPHRASE-NOTYPES 1053 1058	model
T51	KEYPHRASE-NOTYPES 1067 1077	covariance
T52	KEYPHRASE-NOTYPES 1109 1120	elimination
T53	KEYPHRASE-NOTYPES 1151 1156	model
T54	KEYPHRASE-NOTYPES 1165 1179	mean structure
T55	KEYPHRASE-NOTYPES 1181 1190	Inference
T56	KEYPHRASE-NOTYPES 1205 1215	comparison
T57	KEYPHRASE-NOTYPES 1228 1234	groups
T58	KEYPHRASE-NOTYPES 1257 1262	model
T59	KEYPHRASE-NOTYPES 1264 1289	Significant omnibus tests
T60	KEYPHRASE-NOTYPES 1294 1309	ITT differences
T61	KEYPHRASE-NOTYPES 1326 1332	groups
T62	KEYPHRASE-NOTYPES 1338 1342	time
T63	KEYPHRASE-NOTYPES 1344 1355	two-sided α
T64	KEYPHRASE-NOTYPES 1379 1399	pairwise comparisons
T65	KEYPHRASE-NOTYPES 1405 1413	p values
T66	KEYPHRASE-NOTYPES 1424 1428	post
T67	KEYPHRASE-NOTYPES 1433 1438	tests
